Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 42%
Buy 46%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

Intuitive Surgical is well-positioned to benefit from the growing roboticsurgery market, with over 10,000 da Vinci systems placed worldwide and a low globalpenetration of less than 5%. With the recent launch of the DV5 robotic system and plans for further enhancements, Intuitive is poised for continued growth and potentially re-accelerated procedure growth. The company's strong financials and history of investing in innovation, such as their recently-announced extended-use instrument program and plans for a new GI/endoscopy robot, demonstrate their commitment to driving future growth. While there are concerns about competition and market uncertainties, Intuitive's dominant market position and strong balance sheet provide a sustainable advantage for years to come.

Bears say

Intuitive Surgical is facing significant challenges, reflected in their consecutive downward revisions for higher price targets as they posted a solid 2Q with procedure growth (~16%), which implies a slight slowdown. While their recent survey shows dominant competitiveness, the company continues to face headwinds like the ACA subsidy expiration and more challenging procedures. Moreover, ASPs are decreasing with every quarter, which suggests a possible downward trend in demand over the long term.

Intuitive Surgical (ISRG) has been analyzed by 24 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 46% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 24 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Sep 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $535.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $535.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.